Phase 3 Rhinoconjunctivitis Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
RhinoconjunctivitisRhinitis
Inmunotek S.L.736 enrolled19 locationsNCT07348302
Recruiting
Phase 3
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
Allergic RhinitisAllergic Rhinoconjunctivitis
ALK-Abelló A/S300 enrolled30 locationsNCT07060885
Recruiting
Phase 3
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.150 enrolled32 locationsNCT04435990
Recruiting
Phase 3
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.180 enrolled27 locationsNCT04898283
Recruiting
Phase 3
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.180 enrolled32 locationsNCT04891237